Frontlight ResearchEarly access
Trial site
Stanford Neuroscience Health Center
- 13running trials
- 2closed trials
The trials here
What the 16 trials at this site are about, from their registry records.
- Conditions
- Alzheimer disease3 trials
- Spinal muscular atrophy3 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 trials
- Duchenne muscular dystrophy2 trials
- Lewy body dementia2 trials
- Migraine1 trial
- Mild cognitive impairment1 trial
- Multiple sclerosis1 trial
- Multiple system atrophy1 trial
- Myasthenia gravis1 trial
- Myotonic dystrophy1 trial
- Parkinson disease1 trial
- and 1 more
- Phase
- Phase 38 trials
- Phase 24 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed2 trials
- Not yet recruiting2 trials
- Enrolling by invitation1 trial
- Suspended1 trial
- Lead sponsor
- Biogen2 trials
- Edgewise Therapeutics, Inc.2 trials
- Eli Lilly and Company2 trials
- AskBio Inc1 trial
- BlueRock Therapeutics1 trial
- and 8 more
Running trials
Recruiting
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Enrolling by invitation
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Alzheimer disease2 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)2 recruiting
- Duchenne muscular dystrophy1 recruiting
- Lewy body dementia1 recruiting
- Mild cognitive impairment1 recruiting
- Multiple sclerosis1 recruiting
- Myasthenia gravis1 recruiting
- Myotonic dystrophy1 recruiting
- Parkinson disease1 recruiting
- Pompe disease1 recruiting
- Spinal muscular atrophy1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026